The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1072
February 21, 2000
View Complete Issue         Table of Contents 2019 
Aspirin For Primary Prevention of Cardiovascular Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Aspirin For Primary Prevention of Cardiovascular Disease
February 21, 2000 (Issue: 1072)
Some readers have asked whether the widespread practice of taking aspirin to prevent first heart attacks is justifiable and, if so, what the dose should be. Only one large well-designed study has tested the use of aspirin for this purpose.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Aspirin For Primary Prevention of Cardiovascular Disease
Article code: 1072c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.